Epicardial adipose tissue may predict new-onset atrial fibrillation in patients with ST-segment elevation myocardial

Hayati Eren1, Muhammed Bahadir Omar2, Ülker Kaya1

  • 1Department of Cardiology, Elbistan State Hospital, Kahramanmaraş.

Insights

Increased epicardial adipose tissue (EAT) thickness is a significant predictor of new-onset atrial fibrillation in ST-elevation myocardial infarction (STEMI) patients after primary percutaneous coronary intervention (pPCI). This finding suggests EAT thickness can serve as a valuable cardioembolic risk factor.

Area of Science:

  • Cardiology
  • Cardiac Imaging
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a common complication following ST-elevation myocardial infarction (STEMI).
  • Epicardial adipose tissue (EAT) has been implicated in the pathophysiology of various cardiovascular diseases.
  • The role of EAT thickness in predicting AF development post-STEMI requires further elucidation.

Purpose of the Study:

  • To investigate the relationship between epicardial adipose tissue (EAT) thickness and the incidence of new-onset atrial fibrillation (AF) in patients with STEMI.
  • To determine if EAT thickness is an independent predictor of AF development in the post-primary percutaneous coronary intervention (pPCI) period.

Main Methods:

  • A cohort of 413 STEMI patients undergoing pPCI was studied.
  • EAT thickness was measured using transthoracic echocardiography.
  • Logistic regression analysis was employed to identify independent predictors of AF.

Main Results:

  • Patients who developed AF had significantly higher EAT thickness compared to controls (P < 0.001).
  • EAT thickness was positively correlated with the SYNTAX score (r = 0.523, P < 0.001).
  • Logistic regression identified EAT thickness as an independent predictor of AF (OR: 4.135, 95% CI: 1.245-8.176, P < 0.001).

Conclusions:

  • Epicardial adipose tissue thickness is a significant marker for AF development in STEMI patients post-pPCI.
  • EAT thickness may serve as a useful cardioembolic risk factor in this patient population.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
84
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
134